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AbstrACt
Objective Validation of the intracerebral haemorrhage 
(ICH) score in patients with a diagnosis of spontaneous ICH 
admitted to the intensive care unit (ICU).
Methods A multicentre cohort study was conducted in all 
consecutive patients with ICH admitted to the ICUs of three 
hospitals with a neurosurgery department between 2009 
and 2012 in Andalusia, Spain. Data collected included 
ICH, Glasgow Coma Scale (GCS) and Acute Physiology 
and Chronic Health Evaluation II (APACHE-II) scores. 
Demographic data, location and volume of haematoma 
and 30-day mortality rate were also collated.
results A total of 336 patients were included. 105 of 
whom underwent surgery. Median (IQR) age: 62 (50–70) 
years. APACHE-II: 21(15–26) points, GCS: 7 (4–11) 
points, ICH score: 2 (2–3) points. 11.1% presented with 
bilateral mydriasis on admission (mortality rate=100%). 
Intraventricular haemorrhage was observed in 58.9% 
of patients. In-hospital mortality was 54.17% while 
the APACHE-II predicted mortality was 57.22% with a 
standardised mortality ratio (SMR) of 0.95 (95% CI 0.81 to 
1.09) and a Hosmer-Lemenshow test value (H) of 3.62 (no 
significant statistical difference, n.s.). 30-day mortality was 
52.38% compared with the ICH score predicted mortality 
of 48.79%, SMR: 1.07 (95% CI 0.91 to 1.23), n.s. Mortality 
was higher than predicted at the lowest scores and lower 
than predicted in the more severe patients, (H=55.89, 
p<0.001), Gruppo Italiano per la Valutazione degli 
Interventi in Terapia Intensiva calibration belt (p<0.001). 
The area under a receiver operating characteristic (ROC) 
curve was 0.74 (95% CI 0.69 to 0.79).
Conclusions ICH score shows an acceptable 
discrimination as a tool to predict mortality rates in 
patients with spontaneous ICH admitted to the ICU, but its 
calibration is suboptimal.
IntrOduCtIOn 
Patients with spontaneous, non-traumatic 
acute intracerebral haemorrhage (ICH) 
represent 9%–27% of all strokes world-
wide, with an annual incidence of 10–30 per 
100 000 population.1–7 The highest mortality 
rate among patients with stroke is observed 
in those with ICH, and it is estimated at close 
to 50%.2 8 9 A large proportion of patients 
with ICH are admitted to the intensive care 
unit (ICU), and these have a significantly 
higher mortality rate. Specifically so in 
hospitals that participate in organ donation 
programmes, where these patients with ICH 
are often admitted to the ICU with little or no 
chances of survival in order to consider organ 
donation.
strengths and limitations of this study
 ► This is a prospective multicentre cohort study with 
the purpose of validating the intracerebral haemor-
rhage (ICH) score, including all consecutive patients 
presenting with diagnosis of spontaneous ICH and 
admitted to intensive care unit (ICU).
 ► When predicting mortality, we compared the ob-
served discrimination and calibration for ICH score 
with the corresponding values analysing Acute 
Physiology and Chronic Health Evaluation II score in 
a similar way.
 ► The statistical analysis was performed through con-
ventional tests used in validation studies, including 
area under the ROC curve, Hosmer-Lemeshow and 
Gruppo Italiano per la Valutazione degli Interventi in 
Terapia Intensiva tests.
 ► We did not analyse in this study any clinical differ-
ences between patients coming from the emergency 
department and patients admitted to ICU.
 ►  Considering pupillary changes as a modification 
item in the ICH score might increase its prognostic 
accuracy when assessing specifically ICU patients: 
a bigger number of patients coming from more par-
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Recently, we published a paper about the usefulness 
of surgery in patients with spontaneous ICH,10 demon-
strating that the mortality rate was particularly high in 
the population of this multicentre cohort study. There-
fore, we posed the question about whether or not this 
high observed mortality rate was in accord with the 
predicted one using one of the most widespread prog-
nostic scores (PSs) for this kind of patients: the ICH 
score.9
The ICH score was originally developed for patients 
with spontaneous ICH admitted to the emergency depart-
ment (ED) and not to ICU. It is a simple PS that anal-
yses just five variables and provides quick, easy and useful 
prognostic information for health professionals and rela-
tives in the decision-making process.9 As a quality control 
this PS will allow us to analyse whether the observed 
mortality in an analysed population is less or greater than 
the described one by the original PS author and validated 
with this purpose.11 12
Several specific PSs have been proposed for patients 
admitted to ICU.11 12 Among the most used ones are 
the Acute Physiology and Chronic Health Evaluation 
(APACHE), the Simplified Acute Physiologic Score 
(SAPS) and the Mortality Probability Model (MPM). A 
previous version of one of these, APACHE-II,13 it is prob-
ably one of the most used PSs worldwide. In comparison 
to the ICH score, these ICU prognostic systems analyse 
a more exhaustive number of variables, providing more 
accurate prognostic information. However, they are more 
laborious and difficult to calculate and therefore not so 
easily applicable in daily clinical practice.
Any given PS should be evaluated in populations of 
patients different from that in which it was originally 
described. The original ICH score study was performed 
in ED patients, and it is mainly in this group where most 
current studies have been performed. Some research has 
been performed exclusively in ICU patients,14–16 although 
they have not focused in the validation of the ICH score 
comparing it with other accurate ICU scores.
As the popular and widespread ICH score is frequently 
used in current ICU practice, we aimed our research to 
validate it in the critical care patient group. The objec-
tive of this study was the validation of the ICH score in 
patients with a diagnosis of ICH admitted to the ICU.
MAterIAls And MethOds
We performed a multicentre cohort study including all 
consecutive 336 patients presenting with a diagnosis of 
spontaneous ICH from October 2009 to January 2012 
to the ICUs of three hospitals in Andalusia (Regional 
University Hospital of Málaga, University Hospital Virgen 
de las Nieves, Granada and Neurotrauma Hospital, Jaén). 
All participating hospitals are tertiary referral centres 
for neurosurgical conditions in the region, providing 
comprehensive facilities for treatment of patients with 
acute stroke, including neurology, neuroradiology, 
neurosurgery and critical care. These hospitals frequently 
collaborate in multicentre studies10 17 and participate in 
organ donation programmes.
The inclusion criteria were patients over 14 years of age 
with acute ICH confirmed on CT imaging of the brain 
with or without intraventricular extension. Patients with 
a history of trauma, those with aneurysmal subarachnoid 
haemorrhage or underlying parenchymal lesions were 
excluded. 
After admission patients underwent diagnostic imaging 
and treatment procedures according to the best clinical 
practice guidelines at the time of inclusion.18
The attending neurosurgeon was routinely consulted to 
assess the need for surgical haematoma evacuation and/
or insertion of external ventricular drainage (EVD). The 
decision for surgical treatment was made following local 
guidelines for clinical practice or when the attending 
neurosurgeon considered it necessary. When a surgical 
decision was made for clot evacuation, a standard crani-
otomy with corticotomy and haematoma aspiration was 
carried out in all cases, with or without EVD placement.
For this cohort study, data were collected by specifi-
cally trained physicians in each hospital. Data collected at 
admission included age, admission Glasgow Coma Scale 
(GCS), APACHE-II, pupillary changes at ICU admission, 
haematoma volume and location (haematomas originated 
in the supratentorial compartment were classified into 
lobar vs basal ganglia/thalamic), presence of intraventric-
ular haemorrhage (IVH) and ICH score. Volume of the 
haematoma was calculated according to the admission CT 
scan and applying the formula AxBxC/2, being A, B and 
C the maximal diameters of the clot in the three planes 
of space.8 19 ICH score was used evaluating five items: GCS 
(13–15:0, 5–12:1, 3–4:2 points), age (<80:0, >80:1 point), 
infratentorial origin of ICH (No:0, Yes:1 point), ICH 
volume (<30cc:0, >30cc:1 point) and presence of IVH 
(No:0, Yes:1 point).9 We collected GCS on ICU admission 
and worst GCS on first ICU day. Although the original 
ICH score study assessed GCS score at discharge from the 
emergency room, this value is similar to the GCS on ICU 
admission used in our study.
Intervention and outcome data were subsequently 
collected including insertion of EVD and/or surgical 
evacuation of the clot, length of ICU admission, and 
30 days, ICU and overall hospital mortality. Most of these 
variables were routinely registered in the clinical notes 
and easily identifiable from the electronic records with a 
low rate of missing data. Data collection was prospective 
in Málaga (148 patients) and Granada (93 patients). Jaén 
Hospital (95 patients) joined the study later (January 
2010), so data collection there was partially retrospective. 
Data were analysed anonymously. 
Quantitative variables were expressed as median and 
IQR, qualitative variables as percentages and frequencies. 
Non-parametric tests were used to compare continuous 
variables, applying the Mann-Whitney U test for compar-
isons of two independent samples. Multivariate analysis 
was performed using a multiple logistic regression model. 
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mortality (table 1) in this multivariate analysis, consid-
ering that they could improve the prognostic accuracy of 
the ICH score without increasing its complexity.
Standard mortality ratio (SMR), Hosmer-Lemeshow20 
test and (Gruppo Italiano per la Valutazione degli Inter-
venti in Terapia Intensiva, GiViTi) calibration belt21 22 
were used to assess the agreement between observed and 
predicted mortality. The area under the ROC curve was 
used to analyse discrimination.23 PSPP ( psppire. exe 
0.7.8.) and ‘R V.3.4.1’ were used for statistical analysis.
Patient and public involvement
The patients and or public were not involved in the 
design, in the recruitment or conduct of the study.
results
Three hundred and thirty-six patients were recruited: 148 
from Málaga, 93 from Granada and 95 from Jaén hospital. 
Median (IQR) age was 62 (50–70) years and GCS on ICU 
admission was 7 (4–11) points. On admission median 
Table 1 Relationship between hospital mortality and rest of variables (age expressed in years, GCS, APACHE-II and ICH 








Age 62(50–70) 58(45–66) 65(55–74) <0.001
Admission GCS 7 (4–11) 10 (7–14) 6 (4–8) <0.001
Worst GCS on first ICU day 6 (3–10) 8.5 (6–13) 4 (3–7) <0.001
Length of ICU stay 5 (2–10) 7 (3–14) 3 (1–7) <0.001
APACHE-II 21 (15–26) 17 (12–22) 24 (20–29) <0.001
Probability of death (APACHE-II) 0.59 (0.35–0.79) 0.39 (0.26–0.6) 0.74 (0.54–0.85) <0.001
ICH score 2 (2–3) 2 (1–3) 3 (2–4) <0.001
Probability of death (ICH) 0.26 (0.26–0.72) 0.26 (0.13–0.60) 0.72 (0.26–0.97) <0.001
Admission pupillary changes* <0.001
  Normal 71.8% (n=239) 91.5% (n=140) 55% (n=99)
  Anisocoria 17.1% (n=57) 8.5% (n=13) 24.4% (n=44)
  Bilateral non-reactive mydriasis 11.1% (n=37) 0% (n=0) 20.6% (n=37)
Volume of haematoma 0.031
  <30 mL 44.9% (n=151) 51.3% (n=79) 39.6% (n=72)
  >30 mL 55.1% (n=185) 48.7% (n=75) 60.4% (n=110)
Origin of the ICH 0.514
  Supratentorial 78.3% (n=263) 79.9% (n=123) 76.9% (n=140)
  Infratentorial 21.7% (n=73) 20.1% (n=31) 23.1% (n=42)
Haematoma site in supratentorial location† 0.6
  Lobar 54% (n=141) 55.7% (n=68) 52.5% (n=73)
  Basal ganglia/thalamic 66% (n=120) 44.3% (n=54) 47.5% (n=66)
Intraventricular haemorrhage 0.03
  No 41.1% (n=138) 50% (n=77) 33.5% (n=61)
  Yes 58.9% (n=198) 50% (n=77) 66.5% (n=121)
External ventricular drain 0.14
  No 79.5% (n=267) 76% (n=117) 82.4% (n=150)
  Yes 20.5% (n=69) 24% (n=37) 17.6% (n=32)
Surgical treatment <0.001
  No 68.8% (n=231) 59.4% (n=95) 77.3% (n=136)
  Yes 31.2% (n=105) 40.6% (n=65) 22.7% (n=40)
Quantitative variables are expressed as median and 25th–75th percentiles interval.
*Admission pupillary changes data were missed in three patients.
†Haematoma site in supratentorial location data were missed in 2 of 263 patients with supratentorial origin of the haematoma. Calculations 
were made regarding these 261 patients.
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APACHE-II severity score was 21 (15–26) points and ICH 
score was 2 (2–3) points. 28.2% of the patients had pupil-
lary anomalies on admission (11.1% had bilateral non-re-
active mydriasis). In 263 cases, the origin of the ICH 
was supratentorial and IVH was present in 58.9% of the 
patients. One hundred and five patients were surgically 
treated.
Hospital mortality rate was 54.17%. Patients who 
died during their hospital stay were significantly older, 
had lower GCS on admission and higher APACHE-II 
scores (table 1). Predicted mortality rate according to 
APACHE-II was 57.22%, and it was comparable with the 
observed one. SMR was 0.95 (95% CI 0.81 to 1.09), with 
no significant statistical difference (n.s.). The agreement 
between the APACHE-II predicted and observed mortality 
rates was also analysed using the Hosmer-Lemenshow test 
(H=3.62, n.s., table 2, figure 1) and the GiViTI calibra-
tion belt (p=0.430, n.s., supplemental digital content—
figure 2), with no statistically significant difference 
observed. Discrimination for the APACHE-II using the 
area under the ROC curve was 0.80 (95% CI 0.74 to 0.84).
The observed 30-day mortality rate was 52.38% 
compared with a predicted ICH score mortality rate of 
48.79%. SMR was 1.07 (95% CI 0.91 to 1.23), n.s. Observed 
and predicted mortality rates in the different ICH score 
groups (table 3) were: 0 points (n=10): 10% vs 0%; 1 point 
(n=54): 22.2% vs 13%; 2 points (n=115): 42.6% vs 26%; 
3 points (n=102): 65.7% vs 72%; 4 points (n=47): 85.1% 
vs 97%; 5 points (n=7): 85.71% vs 100%; 6 points (n=1): 
100% vs 100%. The observed mortality rate was therefore 
higher in comparison to that predicted in the low ICH 
scores, and lower in the high scores (3, 4 and 5 points). 
Hosmer-Lemeshow test (H) was 55.89 (p<0.001), with 
significant statistical difference in the agreement between 
the ICH score predicted and observed mortality rates 
(table 4). The GiViTi calibration belt showed a significant 
difference (p<0.001) between both rates as well (supple-
mental digital content–figure 3). Discrimination for the 
ICH score using the area under the ROC curve was 0.74 
(95% CI 0.69 to 0.79).
28.2% of patients (n=94) showed pupillary anomalies 
(anisocoria or bilateral mydriasis) on admission, with a 
30-day observed mortality rate of 85% and an ICH score 
predicted one of 68.5%. When analysing the particular 
subgroup of 37 patients (11.1%) with bilateral mydriasis, 
30-day mortality was 100% vs 78.11% ICH score predicted 
rate. In 239 patients with no pupillary anomalies, 30-day 
observed mortality rate was 39.33%, very similar to the 
42.89% predicted by the ICH score.
Multiple logistic regression analysis showed a signifi-
cant relationship between 30-day hospital mortality rate 
and ICH score predicted mortality, OR 1.02 (95% CI 1.01 
to 1.03), and with pupillary anomalies seen on admission 
to ICU, OR 5.72 (95% CI 2.96 to 11.04). The area under 
the ROC curve was 0.80 (95% CI 0.75 to 0.84) according 
to this model. When including in the model the variable 
worst GCS on first ICU day, for ICH score the OR was 
1.59 (95% CI 1.17 to 2.16), for pupillary anomalies OR 
was 3.90 (95% CI 1.97 to 7.75) and for worst GCS on first 
ICU day the OR was 0.83 (95% CI 0.76 to 0.91). The area 
under the ROC curve was 0.81 (95% CI 0.77 to 0.86) 
according to this model.
dIsCussIOn
Our study shows that ICH score is useful for evaluating the 
severity of patients with ICH admitted to ICU, although 
it does not meet all the necessary requirements for its 
validation.
Its discrimination is acceptable, but with respect to 
its calibration we have detected a significant difference 
between the observed and predicted mortality rates, this 
difference being slightly higher than the accepted one for 
validation. This difference does not seem to be important 
enough to invalidate this predictive scale, and therefore 
the ICH score can be considered as a useful tool for the 
evaluation of patients with spontaneous ICH. An adapta-
tion to the ICU patients may be considered in the future 
to achieve a more precise predictive value of the score in 
the critical patient.
Our research also shows that patients with pupillary 
anomalies on admission are a very important source of 
discrepancies between observed and predicted mortality. 
The three participating hospitals included in our analysis 
are centres with organ donation programmes, and that 
Table 2 Performance of the APACHE-II score: Goodness of 






Deaths, n Survivors, n
Observed Predicted Observed Predicted
≤0.20 19 1 2.55 18 16.45
>0.20–0.40 75 19 22.22 56 52.78
>0.40–0.60 64 29 31.01 35 32.99
>0.60–0.80 79 57 56.18 22 22.82
>0.80 78 65 68.61 13 9.39
The Hosmer-Lemeshow test was 3.62 (not statistically significant).
APACHE-II, Acute Physiology and Chronic Health Evaluation II. 
Figure 1 Predicted versus observed hospital mortality for 






















pen: first published as 10.1136/bm





5Rodríguez-Fernández S, et al. BMJ Open 2018;8:e021719. doi:10.1136/bmjopen-2018-021719
Open access
increases the number of observed patients with pupillary 
anomalies (including those with bilateral mydriasis). This 
fact can be extended to almost all ICUs with Donation 
and Transplant Programme. Multivariate analysis in our 
research showed that the presence of pupillary anomalies 
(classified in anisocoria and bilateral non-reactive mydri-
asis) it is a predictive factor that complements the ICH 
score, and it could be used as a possible adaptation of 
it. Pupillary changes are routinely examined in patients 
with spontaneous ICH, and further research could clarify 
if this easily identifiable sign would improve calibration 
of the ICH score when assessing specifically ICU patients.
Our study also shows that worst GCS on first ICU day (an 
included item in APACHE-II score) is a significant factor 
after multivariate analysis, this sequential clinical variable 
could also contribute to a more accurate prognosis.
ICH score has been validated worldwide through several 
studies9 24–27 in different populations.28–32 However, the 
ICH score has been scarcely validated in ICH patients 
specifically admitted to the ICU.14–16 This prognostic 
tool was originally created for evaluation of ICH patients 
admitted to the ED before they were moved to ward, 
ICU or operating theatre, or excluded from resuscitation 
manoeuvres.
We have not specifically studied differences between 
ICU and ED patients, neither have we collected data 
about Do Not Resuscitate/Do Not Intubate orders in the 
ED. Some patients never even reach the ICU from the 
ED, and as a result, are excluded from the ICU validation 
and not the ED. ICU admitted patients usually do not 
include those with mild symptoms and minimal haem-
orrhage, but instead those coming from the operating 
theatre after surgical evacuation of the clot and sometimes 
those considered non-recoverable and admitted just for 
support measurements/transplant intention. These clin-
ical biases introduced by a different type of population 
in comparison to ED patients can explain the suboptimal 
calibration of ICH score when applied exclusively in ICU 
patients, and establishes a limitation in our study that will 
need clarification in further research. There may be char-
acteristics in patients with ICH that may explain why these 
patients survived to the ICU when others did not.
Figure 2 APACHE-II calibration. APACHE-II, Acute Physiology and Chronic Health Evaluation II. 
Table 3 Observed and predicted 30-day mortality rates 
according to intracerebral haemorrhage (ICH) score
ICH score n Observed (%) Predicted (%)
0 10 10 0
1 54 22.2 13
2 115 42.6 26
3 102 65.72 72
4 47 85 97
5 7 85.71 100
6 1 100 100
Table 4 Performance of the ICH score: Goodness of fit 






Deaths, n Survivors, n
Observed Predicted Observed Predicted
≤0.25 64 13 7.02 51 56.98
>0.25–0.5 115 49 29.9 66 85.1
>0.5–0.75 102 67 73.4 35 28.6
>0.75 55 47 53.59 8 1.41
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The rate of operated patients (31.2%) in our study 
can be considered high, but similar to other series.16 
The role of surgery for most patients with spontaneous 
ICH remains controversial. Randomised trials comparing 
surgery to conservative management have not demon-
strated a clear benefit for surgical intervention. Moreover, 
the generalisability of the results of these trials can be 
questioned, because patients at risk for herniation were 
likely excluded and the largest and most recent studies 
had high rates of treatment group crossover from conser-
vative management to surgery. STICH trial33 found no 
overall statistically significant difference in mortality or 
functional outcome between treatment groups. Notably, 
26% of patients initially assigned to conservative manage-
ment ultimately underwent surgery. Our data were 
collected between the publication of the results of the 
STICH33 and STICH-II trials,34 which could have influ-
enced the neurosurgical decision-making in the three 
participating centres.
These studies performed exclusively on ICU patients 
have not focused on the topic of the validation of the 
score in critically ill patients. Fang et al16 analysed a group 
of ICU patients with non-traumatic ICH, focusing on 
the influence of coagulation disorders in these patients. 
The authors also provide data on the number of patients 
included in each of the scores and their mortalities, 
which allows us to see the functioning of the ICH score in 
their patients; in the 0 points group (n=15) the observed 
and predicted mortality rate was 0%, in the 1 point group 
(n=22) the observed and predicted rates were 9% and 
13%, respectively, in the 2 points group (n=43) they 
were 23% vs 26%, in the 3 points group (n=19) 58% vs 
72%, and in the 4 points group (n=10) the observed and 
predicted mortality rates were 50% vs 97%. Thirty days 
observed and predicted mortality rates were 25.7% vs 
34.23%, respectively. Performing the Hosmer-Lemen-
show test on these data, we find a statistically significant 
difference (H=78.23, p<0.001) in the agreement between 
the observed and predicted mortality rates. As we noticed 
in our patients, the most significant differences are found 
in the more severe groups of patients, where ICH score 
overestimates mortality rates. Another study specifically 
performed in ICU patients is that of Godoy et al,14 where 
observed and predicted mortality rates according to 
ICH scores were: 0 points: 0% vs 0%, 1 point: 2.9% vs 
13%, 2 points: 30.8% vs 26%, 3 points: 61.1 % vs 72%, 
4 points: 88.2% vs 97%). In this paper, we observe scant 
discrepancies in the different scores and the authors 
conclude that there is a good agreement between what 
was observed and predicted. In a third study performed 
in ICU patients,15 similar differences were also noticed in 
observed and predicted mortalities (0 points: 11.11% vs 
0%, 1 point: 12.5% vs 13%, 2 points: 44.44% vs 26%, 3 
points: 70% vs 72%, 4 points: 100% vs 97%). In this last 
study, the number of included patients studied was only 
37, and therefore, it is difficult to draw reliable conclu-
sions from it.
The analysis of the data in these papers agrees with the 
results from our study: the calibration of the ICH score 
is suboptimal. Significantly, the observed mortalities in 
the more severe groups of patients are inferior to those 
predicted by the ICH score. However, we believe that this 
is an easy-to-use instrument and that it is useful when eval-
uating the severity of patients to provide the attending 
doctor and relatives with quick and simple information 
about a patient’s condition and approximate prognosis. 
The ICH score, however, does demonstrate an inadequate 
calibration in the most critical patients, and therefore, 
currently it cannot be considered as a precise outcome 
predictor.
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The calibration discrepancies we observe may warrant 
an adaptation of the instrument to critical care patients in 
the future. Several studies have attempted to improve its 
sensitivity, specificity and its usefulness for the prognostic 
evaluation of morbidity by adding variations to it. Cheung 
and Zou26 use a modified ICH score where National 
Institute of Health Stroke Scale, temperature and pulse 
pressure are added. Wang et al27 and Ruiz-Sandoval et al31 
compared ICH score and ICH grading scale score. Both 
indexes analyse the same parameters but they attribute 
different scores to each parameter.
Multiple PSs have been developed for ICU patients. 
APACHE, SAPS and MPM systems12 13 are probably the 
most widespread ones. These systems can be used on 
most ICU patients including those with acute ICH. They 
evidence a discrimination superior to the found one in 
the ICH score, but they also show the disadvantage of its 
greater complexity.
PSs resulting from a bigger number of variables have 
better discrimination. Validation studies of these scores 
usually do not find discrimination problems, but never-
theless, they show calibration issues, with statistically 
significant differences between the predicted mortality 
calculated by the system and the observed one in the 
study population. We have performed several of these 
validation studies in which we found good discrimination 
but not an adequate calibration in different PSs.17 35 36
We analysed in this study the performance of the 
APACHE-II score as well, showing a higher discrimina-
tion than the calculated one for the ICH score. We also 
found a remarkable good calibration for the APACHE-II, 
a PS that was created more than 30 years ago, and in 
which it would be theoretically expected that the score 
calibration deteriorated over time, due to changes in the 
type of patients and to improvement in treatments. No 
significant difference between predicted and observed 
mortality using APACHE-II was observed with both cali-
bration statistical tests. Current published data on the 
good functioning of APACHE-II in these type of patients 
are available.37 38
The ideal PS to be promoted and developed should be 
simple, with few component variables codified in a simple 
way and with good discrimination capacity. It is about 
finding a balance between simplicity and precision when 
predicting the results.
ICH score was specifically designed for patients with 
non-traumatic ICH. As described in the material and 
methods section, it collects the information according to 
five variables previously identified as significantly related 
to mortality, and it categorises the continuous variables to 
make its use simpler. Scores vary from 0 to 6. Its simplicity 
makes this system intuitive and easy, allowing the physi-
cian quickly to quantify severity and chances of survival in 
the ED. It is a useful method that estimates the chances 
of recovery in a patient prior to admission in the ICU. It 
is not a PS specifically designed for ICU patients, but its 
simplicity makes its use currently widespread among crit-
ically ill patient carers. We cannot validate it in terms of 
calibration, but its discrimination looks good enough to 
allow its use in ICU daily clinical practice. The ICH score 
was developed more than 15 years ago. The advances 
in diagnosis and treatment of patients with ICH have 
improved their survival, and that could make the ICH 
score predictions obsolete. On the other hand, some 
may claim that advances that significantly influence over 
mortality in these patients during last years have been 
scarce, and therefore, ICH score predictions would be 
still reliably up to date.39 40
Regarding the limitations of our study, we believe that 
a bigger number of patients coming from more partic-
ipating hospitals would increase its reliability. However, 
the number of included patients in our multicentre study 
is sufficient to draw statistically significant conclusions.
COnClusIOns
ICH score shows an acceptable discrimination as a tool to 
predict mortality rates in patients with spontaneous ICH 
admitted to the ICU, but its calibration is suboptimal. 
These calibration discrepancies we observe may warrant 
an adaptation of the instrument to critical patients in the 
future.
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